GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoVista Innovative Therapies Inc (OTCPK:OVIT) » Definitions » FCF Yield %

OncoVista Innovative Therapies (OncoVista Innovative Therapies) FCF Yield % : 0.00 (As of Jun. 20, 2024)


View and export this data going back to 2005. Start your Free Trial

What is OncoVista Innovative Therapies FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, OncoVista Innovative Therapies's Trailing 12-Month Free Cash Flow is $-0.26 Mil, and Market Cap is $0.00 Mil. Therefore, OncoVista Innovative Therapies's FCF Yield % for today is 0.00%.

The historical rank and industry rank for OncoVista Innovative Therapies's FCF Yield % or its related term are showing as below:


OVIT's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -14.61
* Ranked among companies with meaningful FCF Yield % only.

OncoVista Innovative Therapies's FCF Margin % for the quarter that ended in Sep. 2015 was 0.00%.


OncoVista Innovative Therapies FCF Yield % Historical Data

The historical data trend for OncoVista Innovative Therapies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoVista Innovative Therapies FCF Yield % Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.95 -21.55 -55.27 -43.18 -17.57

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.16 -19.08 -2.67 -2.13 -1.09

Competitive Comparison of OncoVista Innovative Therapies's FCF Yield %

For the Biotechnology subindustry, OncoVista Innovative Therapies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OncoVista Innovative Therapies's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's FCF Yield % falls into.



OncoVista Innovative Therapies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

OncoVista Innovative Therapies's FCF Yield % for the fiscal year that ended in Dec. 2014 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.232 / 1.320774
=-17.57%

OncoVista Innovative Therapies's annualized FCF Yield % for the quarter that ended in Sep. 2015 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.027 * 4 / 9.89457
=-1.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OncoVista Innovative Therapies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


OncoVista Innovative Therapies FCF Yield % Related Terms

Thank you for viewing the detailed overview of OncoVista Innovative Therapies's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoVista Innovative Therapies (OncoVista Innovative Therapies) Business Description

Traded in Other Exchanges
N/A
Address
14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.
Executives
Alexander Ruckdaeschel director 123 EAST 83RD STREET, APT 3-B, NEW YORK NY 10028
Paul A Mieyal director C/O WEXFORD CAPITAL LP, 411 WEST PUTNAM AVE, SUITE 125, GREENWICH CT 06830
Charles E Davidson 10 percent owner C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Wexford Capital Lp 10 percent owner 777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Joseph Jacobs 10 percent owner C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Spectrum Trading Ltd 10 percent owner 411 WEST PUTNAM AVENUE, SUITE 125, GREENWICH CT 06830

OncoVista Innovative Therapies (OncoVista Innovative Therapies) Headlines

No Headlines